Buscar resultados de ensayos clínicos
Plasmacytoma - 153 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2008-01-31 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Condición:
Fecha: 2008-11-13 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma Condición:
Fecha: 2008-08-06 Intervenciones:
|
| Completed |
Nombre del estudio: Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2008-01-15 Intervenciones:
|
| Completed |
Nombre del estudio: Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2007-12-05 Intervenciones:
|
| Terminated |
Nombre del estudio: Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2007-12-01 Intervenciones:
|
| Completed |
Nombre del estudio: Activated White Blood Cells in Treating Patients Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Stage II or Stage III Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2007-11-30 Intervenciones:
|
| Completed |
Nombre del estudio: High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2007-09-05 Intervenciones:
|
| Completed |
Nombre del estudio: Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2007-08-31 Intervenciones:
|
| Withdrawn |
Nombre del estudio: Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma Condición: Multiple Myeloma and Plasma Cell Neoplasm Fecha: 2007-07-17 Intervenciones:
|